# The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

> **NCT02114645** · NA · UNKNOWN · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Leuprolide acetate
- **DRUG:** vaginal progesterone
- **DRUG:** 4 mg oral estradiol valerate

## Key facts

- **NCT ID:** NCT02114645
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-02
- **Final completion:** 2015-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114645, "The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02114645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*